September 2021 • PharmaTimes Magazine • 4-5
8. Medicine
10. COVID-19
12. Healthcare
14. Industry
A look at the impact of COVID-19 on cancer care in Europe and key learnings from the past 18 months
Philip Lee outlines barriers which prevent people living with epilepsy from feeling included within society
A look at the pandemic-spurred pattern changes in healthcare and their impact on real-world data
Oli Hudson shares the latest intelligence on how the drug funding landscape will be affected by reforms
As the MedTech market grows, manufacturers need to adopt a more joined-up and co-ordinated means of refining technical content
Merlin Piscitelli explores some of the key trends that are set to drive deals through 2021
PharmaTimes talks to Ben Osborn about what he hopes to achieve during his time as president of the ABPI
A look at one patient’s experiences with the degenerative, neurological condition
PharmaTimes talks to Thom Renwick about his role at Roche UK and the future for UK ophthalmology
42-43.
Appointments